James A Katz

409 total citations
7 papers, 131 citations indexed

About

James A Katz is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Dermatology. According to data from OpenAlex, James A Katz has authored 7 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Ophthalmology, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Dermatology. Recurrent topics in James A Katz's work include Ocular Surface and Contact Lens (4 papers), Allergic Rhinitis and Sensitization (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). James A Katz is often cited by papers focused on Ocular Surface and Contact Lens (4 papers), Allergic Rhinitis and Sensitization (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). James A Katz collaborates with scholars based in United States, Switzerland and Italy. James A Katz's co-authors include Elizabeth H Barnes, Paul Karpecki, Eric D. Donnenfeld, Sima Chiva-Razavi, Parag A. Majmudar, Kenneth A. Beckman, Steven J. Lichtenstein, David B. Granet, Kelly K. Nichols and Catherine Nguyen and has published in prestigious journals such as Clinical Therapeutics, Clinical ophthalmology and Journal of Ocular Pharmacology and Therapeutics.

In The Last Decade

James A Katz

7 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A Katz United States 6 65 63 48 43 22 7 131
Nikhil S Gokhale India 8 189 2.9× 150 2.4× 202 4.2× 57 1.3× 23 1.0× 17 343
Concepción De‐Hita‐Cantalejo Spain 10 125 1.9× 126 2.0× 165 3.4× 78 1.8× 13 0.6× 36 258
Yuta Shigeno Japan 9 151 2.3× 215 3.4× 134 2.8× 44 1.0× 54 2.5× 12 293
Alison Ng Canada 9 98 1.5× 243 3.9× 115 2.4× 22 0.5× 53 2.4× 20 290
Christopher Lievens United States 12 178 2.7× 293 4.7× 184 3.8× 42 1.0× 36 1.6× 34 362
Robert Smyth-Medina United States 7 51 0.8× 92 1.5× 45 0.9× 6 0.1× 30 1.4× 11 149
Robert T. Ang United States 4 170 2.6× 152 2.4× 221 4.6× 41 1.0× 12 0.5× 5 283
Sally M. Dillehay United States 11 101 1.6× 269 4.3× 218 4.5× 119 2.8× 30 1.4× 24 323
Gary Jerkins United States 7 49 0.8× 81 1.3× 39 0.8× 5 0.1× 23 1.0× 11 102
Gairik Kundu India 10 125 1.9× 140 2.2× 196 4.1× 49 1.1× 13 0.6× 23 248

Countries citing papers authored by James A Katz

Since Specialization
Citations

This map shows the geographic impact of James A Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A Katz more than expected).

Fields of papers citing papers by James A Katz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A Katz. The network helps show where James A Katz may publish in the future.

Co-authorship network of co-authors of James A Katz

This figure shows the co-authorship network connecting the top 25 collaborators of James A Katz. A scholar is included among the top collaborators of James A Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A Katz. James A Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Katz, James A, Laura M. Periman, Enrica Sarnicola, et al.. (2022). Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease. Clinical Therapeutics. 44(11). 1463–1470. 5 indexed citations
3.
Katz, James A, et al.. (2021). Presbyopia – A Review of Current Treatment Options and Emerging Therapies. Clinical ophthalmology. Volume 15. 2167–2178. 66 indexed citations
4.
Beckman, Kenneth A., et al.. (2021). KPI-121 1% for Pain and Inflammation in Ocular Surgery. Pain Management. 12(1). 17–23. 5 indexed citations
5.
Beckman, Kenneth A., et al.. (2020). Loteprednol Etabonate for the Treatment of Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics. 36(7). 497–511. 25 indexed citations
6.
Katz, James A, et al.. (2007). A New in vivo Rabbit Model That Mimics Human Dosing to Determine the Distribution of 1.0% Prednisolone Acetate Suspensions in the Tears and Aqueous Humor. 48(13). 4314–4314. 1 indexed citations
7.
Granet, David B., et al.. (2007). An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.. PubMed. 1(4). 519–25. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026